Editor's note: This article has been reviewed and updated for accuracy in 2026. The pot industry is a behemoth, with producers and stocks seeing a strong bull market over the last five years. As more states begin to get onboard with decimalization and legalization, the market expands, and the industry continues its march to the dominance of the alternative health sector. The trend isn't slowing down, and as of the end of 2020, cannabis is legal in 36 states for medical use, including in Washington D.C. Cannabis is legal for recreational use in 15 states, with more joining the ranks of freedom every month. According to research from Arcview, legal cannabis sales amounted to $12.4-billion in 2019, with revenues expected to continue to climb to $46.8-billion by 2025. The company forecasts a 38% growth in annual pot sales in 2020, bringing in an estimated $20.4 billion in revenues for the year. With these kinds of growth figures, it's no wonder institutional investors are starting to take notice of the blooming cannabis sector. The onset of legalization means that barriers for entry into the market are loosening, and there are dozens of startups in the cannabis space. From a dazzling variety of <a href=https://herbceo.com/seed-to-sale-crm/ target=_blank data-type=post data-id=2688 r